NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Premier Biotech

Premier Biotech

Private
Minneapolis, MinnesotaHealthcare & Life Scienceshttps://premierbiotech.com/

Last Round

Private Equity

Dec 6, 2022

Company Overview

Premier Biotech is a medical devices and equipment company that provides rapid drug testing diagnostic devices and forensic toxicology laboratory services.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Compliance & Risk, Biotechnology, Workflow Automation

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

drug testingpoint-of-care testingPOCTdrug test kitsoral fluid testingurine drug testlaboratory servicesdrug screeningworkplace drug testingchain of custodyconfirmation testingLC-MS/MSharm reductionbackground screeningadulterant detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Premier Biotech Comparables

Compare Premier Biotech with similar companies based on industry and business-model similarity.

Premier Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Omega Laboratories, Inc.
81%
United States Drug Testing Laboratories
76%
Cordant Health Solutions
76%

Premier Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityDec 6, 2022

Key People

Founding team and executive leadership

Matt M.

Chief Executive Officer

Executive Team

Premier Biotech Investors

Notable investors and investment history

Premier Biotech investors
InvestorRounds
Align CapitalPrivate Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors increased 198% MoM, reaching 6.3K.

  • Jun 1, 2025

    Monthly visitors increased 127% MoM, reaching 14.3K.

Premier Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Premier Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Premier Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersMinneapolis, Minnesota
Employee Range94
Year Founded2009
Last FundingDec 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.